about
Pneumonia in the neutropenic cancer patientAntimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational OpportunitiesSynergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumoniaPneumonia during remission induction chemotherapy in patients with acute leukemia.Vitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001-2006.Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infectionThe intracellular life of Cryptococcus neoformans.Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal responseSafety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.General, but not myeloid or type II lung epithelial cell, myeloid differentiation factor 88 deficiency abrogates house dust mite induced allergic lung inflammation.Inducible epithelial resistance protects mice against leukemia-associated pneumonia.Lung epithelial cells are essential effectors of inducible resistance to pneumonia.Special issue of BJP on respiratory pharmacology.Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral Infections.
P2860
Q26827758-5F01FA89-A5B1-4AE3-909E-0046BBE000D3Q28078911-54502698-B03B-419B-9515-6EDD902FE18EQ28732374-8F4D64F4-AE5B-488F-85B0-4CFDBE540706Q33410062-463E961B-ABEC-49BE-B6B8-198F35B027A4Q35227910-A415D5C0-DF76-4E7B-8DE6-8D230631D869Q36717803-073C94A4-0A15-40FF-98B8-2C5144115C36Q37452401-FDF0307D-5A85-4AC3-B46F-1887735D2AC2Q37548220-775D375F-58DF-4C79-8BF7-52267DD2FAC7Q37558881-B7AB8271-53BF-4FBA-8D6E-F60AB47F0BE6Q38195597-C968AC6E-67F4-41F2-9FA3-7DFFCFDD9CDFQ40541173-3D196097-1498-404E-BFE9-0738C2DC1713Q41563226-6A2CA976-E5B8-45EB-A892-B8C6A59791CAQ42264726-D1DBA9AD-FA64-4B64-A06E-05E1AF64DCD4Q42725432-7DBD2693-9F01-4974-B430-2F4627514080Q54210821-374D162A-256C-4FE7-9A66-3735F3122F5F
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhaled innate immune ligands to prevent pneumonia.
@ast
Inhaled innate immune ligands to prevent pneumonia.
@en
type
label
Inhaled innate immune ligands to prevent pneumonia.
@ast
Inhaled innate immune ligands to prevent pneumonia.
@en
prefLabel
Inhaled innate immune ligands to prevent pneumonia.
@ast
Inhaled innate immune ligands to prevent pneumonia.
@en
P2093
P2860
P1476
Inhaled innate immune ligands to prevent pneumonia.
@en
P2093
Cory J Fox
Leonid Gibiansky
Michael J Tuvim
Nidhi Sachdev
Scott E Evans
P2860
P304
P356
10.1111/J.1476-5381.2011.01237.X
P407
P577
2011-05-01T00:00:00Z